APA

Tamargo B., Márquez Y., Ramírez W., Cedré B., Fresno M. & Sierra G. (20130822). New proteoliposome vaccine formulation from N. meningitidis serogroup B, without aluminum hydroxide, retains its antimeningococcal protectogenic potential as well as Th-1 adjuvant capacity. : BMC immunology.

Chicago

Tamargo Beatriz, Márquez Yanet, Ramírez Wendy, Cedré Bárbara, Fresno Manuel and Sierra Gustavo. 20130822. New proteoliposome vaccine formulation from N. meningitidis serogroup B, without aluminum hydroxide, retains its antimeningococcal protectogenic potential as well as Th-1 adjuvant capacity. : BMC immunology.

Harvard

Tamargo B., Márquez Y., Ramírez W., Cedré B., Fresno M. and Sierra G. (20130822). New proteoliposome vaccine formulation from N. meningitidis serogroup B, without aluminum hydroxide, retains its antimeningococcal protectogenic potential as well as Th-1 adjuvant capacity. : BMC immunology.

MLA

Tamargo Beatriz, Márquez Yanet, Ramírez Wendy, Cedré Bárbara, Fresno Manuel and Sierra Gustavo. New proteoliposome vaccine formulation from N. meningitidis serogroup B, without aluminum hydroxide, retains its antimeningococcal protectogenic potential as well as Th-1 adjuvant capacity. : BMC immunology. 20130822.